World Health Energy Holdings, Inc 8-K/A, filed Aug 22, 2022
World Health Energy Holdings, Inc. (WHEN)
About this 8-K/A
World Health Energy Holdings, Inc filed this 8-K/A on August 22, 2022, reporting on events of June 22, 2022.
Items reported
- Item 2.01: Completed an acquisition or sale of assets
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction | (Commission File | (IRS Employer | ||
| of incorporation | Number) | Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
Item 2.01 Completion of Acquisition or Disposition of Assets
On June 28, 2022, World Health Energy Holdings, Inc., (the “Company” or “WHEN”) disclosed in a Current Report on Form 8-K that the Company completed the acquisition of a 26% equity interest in CrossMobile Sp. z o.o,, a company formed under the laws of Poland (“CrossMobile”). As previously disclosed, on March 22, 2022 the Company, CrossMobile and the shareholders of CrossMobile entered into an Investment Agreement (the “Agreement”) pursuant to which the Company is to purchase 26% of the outstanding common share capital of CrossMobile on a fully diluted basis, in consideration of the issuance by the Company to CrossMobile of 10,000,000,000 restricted shares of Company common stock.
As required under Polish law, the application to increase the share capital of CrossMobile so that CrossMobile is authorized to issue to WHEN the ordinary shares representing the 26% equity stake in CrossMobile, which increase is a pre-requisite under local law to the issuance to WHEN of the CrossMobile equity interest, was filed with the Polish Companies Registrar on June 22, 2022. Following the issuance of the Original 8-K Report, the Company was advised that share capital increase and the issuance to WHEN of the ordinary shares representing 26% equity in CrossMobile may take several weeks. In fact, the share capital increase and the issuance to WHEN of the ordinary shares representing 26% equity in CrossMobile was finally approved by the Polish Companies Registrar on July 22, 2022 and published on August 1, 2022. Accordingly, the closing conditions to the Investment Agreement were completed on July 22, 2022.
| Exhibit No. | Description | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| By: | /s/ Giora Rozensweig | |
| August 22, 2022 | Chief Executive Officer |